209 related articles for article (PubMed ID: 11089533)
1. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
2. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
Chesnokova V; Auernhammer CJ; Melmed S
Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
[TBL] [Abstract][Full Text] [Related]
3. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
Chesnokova V; Kariagina A; Melmed S
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Chesnokova V; Melmed S
Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary cytokine network.
Kariagina A; Romanenko D; Ren SG; Chesnokova V
Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
[TBL] [Abstract][Full Text] [Related]
6. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
8. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
[TBL] [Abstract][Full Text] [Related]
9. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
10. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion.
Akita S; Malkin J; Melmed S
Endocrinology; 1996 Jul; 137(7):3140-3. PubMed ID: 8770940
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
Akita S; Conn PM; Melmed S
J Clin Endocrinol Metab; 1996 Nov; 81(11):4170-8. PubMed ID: 8923879
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
Abbud RA; Kelleher R; Melmed S
Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S
Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
16. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
Akita S; Webster J; Ren SG; Takino H; Said J; Zand O; Melmed S
J Clin Invest; 1995 Mar; 95(3):1288-98. PubMed ID: 7883977
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
Ray DW; Ren SG; Melmed S
Ann N Y Acad Sci; 1998 May; 840():162-73. PubMed ID: 9629248
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface.
Wang Z; Ren SG; Melmed S
Endocrinology; 1996 Jul; 137(7):2947-53. PubMed ID: 8770918
[TBL] [Abstract][Full Text] [Related]
19. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint.
Zelena D; Mergl Z; Foldes A; Kovács KJ; Tóth Z; Makara GB
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1110-7. PubMed ID: 14534078
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis.
Ware CB; Kariagina A; Zonis S; Alon D; Chesnokova V
FEBS Lett; 2005 Aug; 579(20):4465-9. PubMed ID: 16081071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
